CXCL12 and breast cancer: Inhibition of C-X-C motif receptor 4 in fibroblasts, the receptor of CXCL12, resulted in decreased fibrosis, increased infiltration of cytotoxic T lymphocytes, and decreased immunosuppressive microenvironment in metastasized breast cancer models.